[1] 范玉晶, 韩明子. 基质金属蛋白酶和消化道肿瘤的相关性 [J]. 世界华人消化杂志 2004.doi:10.3969/j.issn.1009-3079.2004.09.039
[2] 严冬, 沈琳, 吕尤勇, YAN Dong, SHEN Lin, LV You-yong. MMP-11在胃癌患者血清中的表达及临床意义 [J]. 中国癌症杂志 2007.doi:10.3969/j.issn.1007-3639.2007.12.014
[3] Kim, S, Bell, K, Mousa, SA, Varner, JA. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. [J]. American Journal of Pathology 2000, 4(4).
[4] Cook SJ, Aziz N, McMahon M. [J]. Molecular and Cellular Biology 1999.
[5] Sadeghi M M, Krassilnikova S, Zhang J. Detection of injury-induced vascular remodeling by targeting activated[alpha]v[beta]3 integrin in vivo [J]. Circulation 2004, 110(01).
[6] Naik MU, Mousa SA, Parkos CA, Naik UP. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. [J]. Blood 2003, 6(6).
[7] Perruzzi CA, De Fougerolles AR, Koteliansky VE, Whelan MC, Westlin WF, Senger DR. Functional Overlap and Cooperativity Among alphav and beta1 Integrin Subfamilies During Skin Angiogenesis. [J]. The Journal of Investigative Dermatology 2003, 6(6).
[8] Vellon L, Menendez JA, Liu H, Lupu R. [J]. Differentiation: The Journal of the International Society of Differentiation 2007.
[9] Gasparini, G, Brooks, PC, Biganzoli, E, Vermeulen, PB, Bonoldi, E, Dirix, LY, Ranieri, G, Miceli, R, Cheresh, DA. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. [J]. Clinical cancer research 1998, 11(11). |
